arrow
A

Ashley Otter

uk health security agency (ukhsa)
H指数:32
被引数:7,715

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating the use of the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin to harmonise the readouts between commercial SARS-CoV-2 binding antibody tests: the HARMONY multicentre calibration study

评估首个WHO国际标准抗-SARS-CoV-2免疫球蛋白在商业SARS-CoV-2结合抗体检测中的协调读数效果:HARMONY多中心校准研究

2026-05-110
OAAI
High-throughput multiplex immunoassay for the detection of mpox and MVA-BN vaccination up to 2 years after exposure in Belgium: a retrospective diagnostic accuracy study

高通量多重免疫检测法用于检测暴露后2年内猴痘和MVA-BN疫苗接种情况:一项回顾性诊断准确性研究

2026-04-290
OAAI
Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC

南基伍省(DRC)性工作者及家庭内Ib型猴痘病毒传播的血清学证据

2025-08-010
OAAI
Immunogenicity of concomitant SARS-CoV-2 and influenza fl uenza vaccination in UK healthcare workers: a prospective observational

英国医护人员同时接种SARS-CoV-2和流感疫苗的免疫原性: 一项前瞻性观察

2024-09-011
OA
Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus

海洋海绵微生物为结核杆菌的进化和毒力提供了见解

2024-08-291
OAAI
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immunemediated inflammatory diseases (VROOM study) a randomised, open label, superiority trial
2024-02-016
OAAI
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort

英国SIREN医护人员队列中第二次加强疫苗接种和先前感染SARS-CoV-2的效果

2024-01-019
OA
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study
2023-10-015
OAAI
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals
2023-09-2312
OAAI
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments (vol 13, 13912, 2023)
2023-09-180
OAAI
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara- Bavaria Nordic vaccine against mpox in children: a national outbreak response

对安全性、反应原性和免疫应答的早期评估后单剂量改良痘苗安卡拉-巴伐利亚北欧疫苗对儿童mpox的影响: 全国性疫情应对

2023-09-0114
OAAI
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial

青少年 (Com-COV3) 异源或分段第二次剂量新型冠状病毒肺炎疫苗接种后的反应原性、免疫原性和突破性感染: 一项随机对照试验

2023-09-015
OAAI
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')2 fragments
2023-08-251
OAAI